Skip to main content
68°
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by NeonMind Biosciences Inc.
NeonMind Announces Plan to Launch 10 Clinics for Innovative Treatments as Mental Health Crisis Grows
April 12, 2022
From
NeonMind Biosciences Inc.
Via
AccessWire
Tickers
CSE:NEON
NMDBF
NeonMind to Present at H.C. Wainwright 2nd Annual Psychedelics Virtual Conference
December 02, 2021
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Tickers
CSE:NEON
NMDBF
NeonMind Announces Successful Completion of Pre-IND Consultation with FDA on Clinical Path for Obesity Drug Candidate NEO-001
November 23, 2021
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Tickers
CSE:NEON
NMDBF
NeonMind to Participate in Panel Discussion at Lift & Co. Expo's Psychedelics Business Summit on November 19, 2021
November 17, 2021
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Cannabis
Intellectual Property
Exposures
Cannabis
Intellectual Property
Tickers
CSE:NEON
NMDBF
NeonMind and SRx Health Solutions Announce Strategic Alliance to Establish Specialty Mental Health Clinics for Interventional Psychiatry Treatments
November 08, 2021
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Tickers
CSE:NEON
NMDBF
NeonMind Biosciences Named as a Top Industry Innovator in Inaugural Issue of Psychedelia Magazine
November 05, 2021
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Tickers
CSE:NEON
NMDBF
NeonMind Advances Strategy for Specialty Clinic Launch
September 28, 2021
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Tickers
CSE:NEON
NMDBF
NeonMind Strengthens its Specialty Clinics Advisory Board with Appointment of Mood Disorders and Ketamine Expert Dr. Gustavo Vazquez, MD, PhD.
September 22, 2021
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Tickers
CSE:NEON
NMDBF
NeonMind Appoints Ketamine and Neurostimulation Expert Dr. Roumen Milev, MD, PhD to Specialty Clinic Advisory Board
September 16, 2021
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Tickers
CSE:NEON
NMDBF
NeonMind Announces Divestiture of Consumer Related and Other Non-Core Assets
September 13, 2021
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Tickers
CSE:NEON
NMDBF
NeonMind to Present at H.C. Wainwright 23rd Annual Global Investment Conference
September 08, 2021
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Tickers
CSE:NEON
NMDBF
NeonMind Announces DTC Eligibility
August 25, 2021
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Tickers
CSE:NEON
NMDBF
NeonMind Receives Health Canada Approval for its Functional Mushroom Formulation 'Mindful Blend'
August 17, 2021
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Tickers
CSE:NEON
NMDBF
NeonMind Announces Corporate Update and Strategic Reorganization of its Pharmaceutical Division
August 05, 2021
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Tickers
CSE:NEON
NMDBF
Dr. Sagar Parikh, MD Appointed to NeonMind Specialty Clinics Advisory Board
July 28, 2021
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Tickers
CSE:NEON
NMDBF
NeonMind Provides Integrated Drug Development Plan Update for NEO-001 to Treat Obesity
July 21, 2021
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Tickers
CSE:NEON
NMDBF
NeonMind Announces Launch of Functional Mushroom Coffees as Dietary Supplements in the US
June 29, 2021
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Tickers
CSE:NEON
NMDBF
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.